Maurice O’Kane

6.2k total citations
87 papers, 1.7k citations indexed

About

Maurice O’Kane is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Maurice O’Kane has authored 87 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in Maurice O’Kane's work include Diabetes Management and Research (14 papers), Lipoproteins and Cardiovascular Health (10 papers) and Chronic Disease Management Strategies (9 papers). Maurice O’Kane is often cited by papers focused on Diabetes Management and Research (14 papers), Lipoproteins and Cardiovascular Health (10 papers) and Chronic Disease Management Strategies (9 papers). Maurice O’Kane collaborates with scholars based in United Kingdom, Ireland and United States. Maurice O’Kane's co-authors include Vivien Coates, Brendan Bunting, Steven Watterson, Victoria McGilligan, Raymond Henderson, Ian Young, Yvonne Barnett, Christopher R. Barnett, Mary P.A Hannon-Fletcher and Helene McNulty and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and PLoS ONE.

In The Last Decade

Maurice O’Kane

85 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maurice O’Kane United Kingdom 24 544 382 338 220 183 87 1.7k
Lilly Q. Yue United States 17 255 0.5× 230 0.6× 303 0.9× 262 1.2× 104 0.6× 43 2.3k
Eric S Kilpatrick United Kingdom 24 604 1.1× 157 0.4× 288 0.9× 228 1.0× 55 0.3× 71 1.7k
Jonathan Benn United Kingdom 26 591 1.1× 445 1.2× 444 1.3× 318 1.4× 419 2.3× 83 2.8k
Jennifer Ng United States 21 557 1.0× 261 0.7× 135 0.4× 302 1.4× 150 0.8× 34 2.3k
Nora Nikolac Croatia 21 161 0.3× 222 0.6× 830 2.5× 222 1.0× 82 0.4× 82 1.7k
Alain Nordmann Switzerland 24 485 0.9× 763 2.0× 827 2.4× 214 1.0× 109 0.6× 38 2.7k
Sean A. Coady United States 14 623 1.1× 544 1.4× 173 0.5× 143 0.7× 102 0.6× 15 1.5k
David Seccombe Canada 24 293 0.5× 230 0.6× 480 1.4× 416 1.9× 37 0.2× 57 1.6k
Masahiko Gosho Japan 27 580 1.1× 574 1.5× 169 0.5× 275 1.3× 36 0.2× 182 2.4k

Countries citing papers authored by Maurice O’Kane

Since Specialization
Citations

This map shows the geographic impact of Maurice O’Kane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice O’Kane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice O’Kane more than expected).

Fields of papers citing papers by Maurice O’Kane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice O’Kane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice O’Kane. The network helps show where Maurice O’Kane may publish in the future.

Co-authorship network of co-authors of Maurice O’Kane

This figure shows the co-authorship network connecting the top 25 collaborators of Maurice O’Kane. A scholar is included among the top collaborators of Maurice O’Kane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurice O’Kane. Maurice O’Kane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCarron, Éamon P, et al.. (2025). Improving Familial Hypercholesterolemia Detection Through Implementation of Nurse-led Cascade Screening. British Journal of Hospital Medicine. 86(8). 1–12.
2.
John, Andrew St, Christopher P. Price, Rogier Hopstaken, et al.. (2024). Challenges Associated with the Effective Implementation of New Laboratory Tests—The International Experience. Clinical Chemistry. 70(5). 693–699. 1 indexed citations
3.
McLaughlin, Joseph K., Victoria McGilligan, Steven Watterson, et al.. (2024). Potential Plasma Proteins (LGALS9, LAMP3, PRSS8 and AGRN) as Predictors of Hospitalisation Risk in COVID-19 Patients. Biomolecules. 14(9). 1163–1163. 2 indexed citations
4.
Dyer, Adam H., Éamon Laird, Leane Hoey, et al.. (2022). Reduced kidney function is associated with poorer domain‐specific cognitive performance in community‐dwelling older adults. International Journal of Geriatric Psychiatry. 37(7). 8 indexed citations
5.
Hoey, Leane, Catherine Hughes, Mary Ward, et al.. (2021). Associations of atrophic gastritis and proton-pump inhibitor drug use with vitamin B-12 status, and the impact of fortified foods, in older adults. American Journal of Clinical Nutrition. 114(4). 1286–1294. 28 indexed citations
6.
O’Shea, Paula, Tomás P. Griffin, Vincent Tormey, et al.. (2020). COVID-19 in adults: test menu for hospital blood science laboratories. Irish Journal of Medical Science (1971 -). 189(4). 1147–1152. 11 indexed citations
7.
O’Kane, Maurice, et al.. (2019). Big Data and diabetes: the applications of Big Data for diabetes care now and in the future. Diabetic Medicine. 37(2). 187–193. 25 indexed citations
8.
Parton, Andrew, Victoria McGilligan, Melody Chemaly, Maurice O’Kane, & Steven Watterson. (2018). New models of atherosclerosis and multi-drug therapeutic interventions. Bioinformatics. 35(14). 2449–2457. 14 indexed citations
9.
Ding, Xuemei, Magda Bucholc, Haiying Wang, et al.. (2018). A hybrid computational approach for efficient Alzheimer’s disease classification based on heterogeneous data. Scientific Reports. 8(1). 9774–9774. 38 indexed citations
10.
Henderson, Raymond, Maurice O’Kane, Victoria McGilligan, & Steven Watterson. (2016). The genetics and screening of familial hypercholesterolaemia. Journal of Biomedical Science. 23(1). 39–39. 112 indexed citations
11.
Given, Joanne, et al.. (2015). Understanding barriers to commencing injectable therapy in people with type 2 diabetes. Ulster University Research Portal (Ulster University). 19(6). 214–220.
12.
Given, Joanne, Brendan Bunting, Maurice O’Kane, Fidelma Dunne, & Vivien Coates. (2015). Tele-Mum: A Feasibility Study for a Randomized Controlled Trial Exploring the Potential for Telemedicine in the Diabetes Care of Those with Gestational Diabetes. Diabetes Technology & Therapeutics. 17(12). 880–888. 50 indexed citations
13.
O’Kane, Maurice, Danielle B Freedman, & Brian J. Zikmund‐Fisher. (2015). Can patients use test results effectively if they have direct access?. BMJ. 350(feb11 18). h673–h673. 18 indexed citations
14.
Kearney, Therese, Marie Murphy, Gareth W. Davison, Maurice O’Kane, & Alison Gallagher. (2013). Accumulated brisk walking reduces arterial stiffness in overweight adults: Evidence from a randomized control trial. Journal of the American Society of Hypertension. 8(2). 117–126. 28 indexed citations
15.
O’Kane, Maurice, et al.. (2008). The relationship between socioeconomic deprivation, educational attainment and clinical outcomes in type 2 diabetes: a cohort study. Diabetologia. 51. 3 indexed citations
16.
O’Kane, Maurice, Vivien Coates, & Brendan Bunting. (2006). The efficacy of self blood glucose monitoring in type 2 diabetes: The ESMON Study. Diabetologia. 49. 4 indexed citations
17.
O’Kane, Maurice, et al.. (2001). Determination of a diabetes control and complications trial-aligned HbA1c reference range in pregnancy. Clinica Chimica Acta. 311(2). 157–159. 24 indexed citations
18.
McEneny, Jane, Maurice O’Kane, C. McMaster, et al.. (2000). Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation. Diabetologia. 43(4). 485–493. 43 indexed citations
19.
20.
Wenham, P R, Ian McDowell, Jane McEneny, et al.. (1993). Rare apolipoprotein E variant identified in a patient with Type III hyperlipidaemia. Atherosclerosis. 99(2). 261–271. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lilly Q. Yue Breakdown of academic impact, for papers by Eric S Kilpatrick Breakdown of academic impact, for papers by Jonathan Benn Breakdown of academic impact, for papers by Jennifer Ng Breakdown of academic impact, for papers by Nora Nikolac Breakdown of academic impact, for papers by Alain Nordmann Breakdown of academic impact, for papers by Sean A. Coady Breakdown of academic impact, for papers by David Seccombe Breakdown of academic impact, for papers by Masahiko Gosho
Rankless by CCL
2026